In the next Front Row lecture, Darrell Irvine explains how controlling where vaccine components travel in the body, and when and for how long they’re delivered, can lead to stronger, longer-lasting immune responses. Hear how two approaches from his lab, a new vaccine adjuvant and a gradual dosing strategy, are moving into clinical testing. Grab a seat for November 18!
Associate Professor Adjunct
Department of Integrative Structural and Computational Biology
HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research
The center includes scientists from both the California and Florida campuses of Scripps Research.
Scientists Capture First High Resolution Image of Key HIV Protein Transitional State
Atomic-scale snapshot reveals new regions on HIV’s envelope trimer protein that could be targets for small molecule inhibitor development.